Protein microarrays: Meeting analytical challenges for clinical applications

Cancer Cell

Volumn 3, Issue 4, 2003, Pages 317-325

  Liotta, Lance A ^a   Espina, Virginia ^a   Mehta, Arpita I ^a,d   Calvert, Valerie ^b   Rosenblatt, Kevin ^a   Geho, David ^a   Munson, Peter J ^c   Young, Lynn ^c   Wulfkuhle, Julia ^b   Petricoin III, Emanuel F ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ANTIBODY AFFINITY; BIOINFORMATICS; CANCER DIAGNOSIS; CANCER GROWTH; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; INTERMETHOD COMPARISON; MICRODISSECTION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN DETERMINATION; PROTEIN MICROARRAY; PROTEOMICS; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; REVIEW; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TARGET CELL DESTRUCTION; TUMOR BIOPSY; VALIDATION PROCESS; ANIMAL; BIOTECHNOLOGY; GENETICS; HUMAN; METHODOLOGY; NEOPLASM; SENSITIVITY AND SPECIFICITY;

ANAS; ANAS SP.; AVES; GALLIFORMES;

ANTIBODY; PROTEOME;

ANIMALS; ANTIBODIES; BIOTECHNOLOGY; HUMANS; NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOME; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 10744221765     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00086-2     Document Type: Review

References (53)

1. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature. 411:2001;355-365.
2. Bobrow M.N., Harris T.D., Shaughnessy K.J., Litt G.J. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods. 125:1989;279-285.
3. Bobrow M.N., Shaughnessy K.J., Litt G.J. Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J. Immunol. Methods. 137:1991;103-112.
4. Bowden E.T., Barth M., Thomas D., Glazer R.I., Mueller S.C. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene. 18:1999;4440-4449.
5. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball C.A., Causton H.C., et al. Minimum information bout a microarray experiment (MIAME) - toward standars for microarray data. Nat. Genet. 29:2001;365-371.
6. Carlisle A.J., Prabhu V.V., Elkahloun A., Hudson J., Trent J.M., Linehan W.M., Williams E.D., Emmert-Buck M.R., Liotta L.A., Munson P.J., Krizman D.B. Development of a prostate cDNA microarray and statistical gene expression analysis package. Mol. Carcinog. 28:2000;12-22.
7. Celis J.E., Gromov P. Proteomics in translational cancer research: Toward an integrated approach. Cancer Cell. 3:2003;9-15.
8. Charboneau L. Utility of reverse phase protein arrays: Applications to signaling pathways and human body arrays. Brief. Func. Genomics Proteomics. 1:2002;305-315.
9. Chen G., Gharib T.G., Huang C.C., Thomas D.G., Shedden K.A., Taylor J.M., Kardia S.L., Misek D.E., Giordano T.J., Iannettoni M.D., et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 8:2002;2298-2305.
10. Cutler P. Protein arrays: The current state-of-the-art. Proteomics. 3:2003;3-18.
11. Delehanty J.B., Ligler F.S. A microarray immunoassay for simultaneous detection of proteins and bacteria. Anal. Chem. 74:2002;5681-5687.
12. Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R., Weiss R.A., Liotta L.A. Laser capture microdissection. Science. 274:1996;998-1001.
13. Ge H. UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. Nucleic Acids Res. 28:2000;e3.
14. Greenbaum D., Baruch A., Hayrapetian L., Darula Z., Burlingame A., Medzihradszky K.F., Bogyo M. Chemical approaches for functionally probing the proteome. Mol. Cell. Proteomics. 1:2002;60-68.
15. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
16. Hanash S. Disease proteomics. Nature. 422:2003;226-232.
17. Huels C., Muellner S., Meyer H.E., Cahill D.J. The impact of protein biochips and microarrays on the drug development process. Drug Discov. Today. 7:2002;S119-124.
18. Humphery-Smith I., Wischerhoff E., Hashimoto R. Protein arrays for assessment of target selectivity. Drug Discov. World. 4:2002;17-27.
19. Hunter T. Signaling-2000 and beyond. Cell. 100:2000;113-127.
20. Hunyady B., Krempels K., Harta G., Mezey E. Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J. Histochem. Cytochem. 44:1996;1353-1362.
21. Ideker T., Thorsson V., Ranish J.A., Christmas R., Buhler J., Eng J.K., Bumgarner R., Goodlett D.R., Aebersold R., Hood L. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science. 292:2001;929-934.
22. Jeong H., Tombor B., Albert R., Oltvai Z.N., Barabasi A.L. The large-scale organization of metabolic networks. Nature. 407:2000;651-654.
23. Jessani N., Liu Y., Humphrey M., Cravatt B.F. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc. Natl. Acad. Sci. USA. 99:2002;10335-10340.
24. King G., Payne S., Walker F., Murray G.I. A highly sensitive detection method for immunohistochemistry using biotinylated tyramine. J. Pathol. 183:1997;237-241.
25. Knezevic V., Leethanakul C., Bichsel V.E., Worth J.M., Prabhu V.V., Gutkind J.S., Liotta L.A., Munson P.J., Petricoin E.F. 3rd, Krizman D.B. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics. 1:2001;1271-1278.
26. Kukar T., Eckenrode S., Gu Y., Lian W., Megginson M., She J.X., Wu D. Protein microarrays to detect protein-protein interactions using red and green fluorescent proteins. Anal. Biochem. 306:2002;50-54.
27. Lal S.P., Christopherson R.I., dos Remedios C.G. Antibody arrays: an embryonic but rapidly growing technology. Drug Discov. Today. 7:2002;S143-149.
28. Liotta L.A., Kohn E.C. The microenvironment of the tumour-host interface. Nature. 411:2001;375-379.
29. Liotta L., Petricoin E. Molecular profiling of human cancer. Nat. Rev. Genet. 1:2000;48-56.
30. Liotta L.A., Kohn E.C., Petricoin E.F. Clinical proteomics: personalized molecular medicine. JAMA. 286:2001;2211-2214.
31. MacBeath G. Protein microarrays and proteomics. Nat. Genet. 32:(Suppl):2002;526-532.
32. MacBeath G., Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science. 289:2000;1760-1763.
33. Miller L.D., Long P.M., Wong L., Mukherjee S., McShane L.M., Liu E.T. Optimal gene expression analysis by microarrays. Cancer Cell. 2:2002;353-361.
34. Miller J.C., Zhou H., Kwekel J., Cavallo R., Burke J., Butler E.B., Teh B.S., Haab B.B. Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers. Proteomics. 3:2003;56-63.
35. Morozov V.N., Gavryushkin A.V., Deev A.A. Direct detection of isotopically labeled metabolites bound to a protein microarray using a charge-coupled device. J. Biochem. Biophys. Methods. 51:2002;57-67.
36. Pandey A., Mann M. Proteomics to study genes and genomes. Nature. 405:2000;837-846.
37. Paweletz C.P., Charboneau L., Bichsel V.E., Simone N.L., Chen T., Gillespie J.W., Emmert-Buck M.R., Roth M.J., Petricoin I.E., Liotta L.A. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene. 20:2001;1981-1989.
38. Petach H., Gold L. Dimensionality is the issue: use of photoaptamers in protein microarrays. Curr. Opin. Biotechnol. 13:2002;309-314.
39. Petricoin E.F., Zoon K.C., Kohn E.C., Barrett J.C., Liotta L.A. Clinical proteomics: translating benchside promise into bedside reality. Nat. Rev. Drug Discov. 1:2002;683-695.
40. Phizicky E., Bastiaens P.I., Zhu H., Snyder M., Fields S. Protein analysis on a proteomic scale. Nature. 422:2003;208-215.
41. Schaeferling M., Schiller S., Paul H., Kruschina M., Pavlickova P., Meerkamp M., Giammasi C., Kambhampati D. Application of self-assembly techniques in the design of biocompatible protein microarray surfaces. Electrophoresis. 23:2002;3097-3105.
42. Schweitzer B., Roberts S., Grimwade B., Shao W., Wang M., Fu Q., Shu Q., Laroche I., Zhou Z., Tchernev V.T., et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. 20:2002;359-365.
43. Seong S.Y. Microimmunoassay using a protein chip: optimizing conditions for protein immobilization. Clin. Diagn. Lab. Immunol. 9:2002;927-930.
44. Simone N.L., Remaley A.T., Charboneau L., Petricoin E.F. 3rd, Glickman J.W., Emmert-Buck M.R., Fleisher T.A., Liotta L.A. Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am. J. Pathol. 156:2000;445-452.
45. Sreekumar A., Nyati M.K., Varambally S., Barrette T.R., Ghosh D., Lawrence T.S., Chinnaiyan A.M. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res. 61:2001;7585-7593.
46. Stillman B.A., Tonkinson J.L. FAST slides: a novel surface for microarrays. Biotechniques. 29:2000;630-635.
47. Templin M.F., Stoll D., Schrenk M., Traub P.C., Vohringer C.F., Joos T.O. Protein microarray technology. Trends Biotechnol. 20:2002;160-166.
48. Tyers M., Mann M. From genomics to proteomics. Nature. 422:2003;193-197.
49. Weng S., Gu K., Hammond P.W., Lohse P., Rise C., Wagner R.W., Wright M.C., Kuimelis R.G. Generating addressable protein microarrays with PROfusion covalent mRNA-protein fusion technology. Proteomics. 2:2002;48-57.
50. Wiese R. Analysis of several fluorescent detector molecules for protein microarray use. Luminescence. 18:2003;25-30.
51. Wilson D.S., Nock S. Recent developments in protein microarray technology. Angew Chem. Int. Ed. Engl. 42:2003;494-500.
52. Zhu H., Snyder M. Protein arrays and microarrays. Curr. Opin. Chem. Biol. 5:2001;40-45.
53. Zhu H., Snyder M. Protein chip technology. Curr. Opin. Chem. Biol. 7:2003;55-63.